Tuesday, September 1, 2026, marked the stock market debuts for three Indian companies: Symbiotec Pharmalab, Skyways Air Services, and Hy-Tech Engineers. These initial public offerings (IPOs) collectively raised Rs 2,476 crore, with bidding open from August 24-27. However, their first day of trading saw varied performances, with two companies facing a muted reception and one making a strong premium entry.
Symbiotec Pharmalab Faces Muted Listing
Indore-based pharmaceutical and biotechnology firm Symbiotec Pharmalab, which raised Rs 1,757 crore from its IPO at an issue price of Rs 988 per share, experienced a quiet debut. On the BSE, the stock listed exactly at its issue price of Rs 988. Meanwhile, on the NSE, it opened at a slight discount of 0.99 per cent, trading at Rs 978.20. Ahead of its listing, grey market premiums had suggested potential gains of 23 per cent for investors.
Skyways Air Services Debuts at a Discount
Logistics and freight forwarding company Skyways Air Services also had a challenging start on the stock exchanges. The company, which garnered Rs 583 crore from its IPO with shares priced at Rs 138 apiece, listed at a nearly 10 per cent discount. Its shares opened at Rs 124 on the NSE and Rs 124.50 on the BSE. This performance was notably below grey market expectations, which had indicated listing gains of around 19 per cent.
Hy-Tech Engineers Soars with Strong Premium
In contrast to the other two, Hy-Tech Engineers, an engineering firm specializing in hydraulic fittings, made a robust entry into the market. Having raised Rs 136 crore from its IPO at an issue price of Rs 53 per share, the company saw its stock list at a significant premium. On the NSE, it opened at Rs 75, a 42 per cent increase, while on the BSE, it traded at Rs 72, up 35 per cent. The IPO was heavily oversubscribed, reaching 247.39 times, reflecting strong investor confidence that was largely validated by its impressive debut.